NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.19% | 16.82% | 11.17% | 14.04% | -14.14% |
| Total Depreciation and Amortization | -29.39% | -28.02% | -19.93% | -11.04% | -2.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.24% | 68.17% | 65.59% | 0.95% | 0.54% |
| Change in Net Operating Assets | -1,917.16% | -123.55% | -96.50% | -133.55% | -97.95% |
| Cash from Operations | 9.23% | 11.89% | 10.65% | 3.37% | -34.25% |
| Capital Expenditure | -47.89% | 34.83% | 50.16% | 51.56% | 63.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -47.89% | 34.83% | 50.16% | 51.56% | 63.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 70.35% | 4.68% | 21.24% | 0.03% | 69.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 70.23% | 4.59% | 21.24% | 0.03% | 69.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.15% | 193.84% | 192.64% | 11.69% | 3.37% |